drug · oligonucleotide

intismeran autogene

Phase 2updated 3mo ago

by $MRNA Moderna, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Oligonucleotide drug with a maximum clinical stage of Phase 3 (across all indications), with 2 investigational indications.

all catalysts(0)

nothing on the calendar yet

phase3A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)recruitingn=680
phase3A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)recruitingn=868
phase2A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)recruitingn=160
phase2A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)recruitingn=180
phase2A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)recruitingn=308
phase3A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)completedn=46
phase2A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)active not recruitingn=230
phase3A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)active not recruitingn=1,089

no news has mentioned this drug yet

Data sources

last refreshed 18m ago

Found something off?

5-min edit window · permanent after that

no comments yet — first sniff?